Fidelity Investments’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Fidelity Investments’s Portfolio FMED Stock Details FMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.2M	Sell	707,017 -25,955	-4%	-$657K	﹤0.01%	1882
2026 Q1	$18M	Sell	732,972 -28	-0%	-$728	﹤0.01%	1823
2025 Q4	$19.8M	Buy	733,000 +5	+0%	+$135	﹤0.01%	1779
2025 Q3	$18.3M	Sell	732,995 -43	-0%	-$1.04K	﹤0.01%	1780
2025 Q2	$17.6M	Buy	733,038 +95,250	+15%	+$2.22M	﹤0.01%	1732
2025 Q1	$15.1M	Sell	637,788 -22,576	-3%	-$570K	﹤0.01%	1783
2024 Q4	$16.3M	Sell	660,364 -3,236	-0.5%	-$83.4K	﹤0.01%	1793
2024 Q3	$17.4M	Sell	663,600 -66,239	-9%	-$1.67M	﹤0.01%	1756
2024 Q2	$17.6M	Sell	729,839 -10,841	-1%	-$262K	﹤0.01%	1696
2024 Q1	$18.9M	Buy	740,680 +20,744	+3%	+$513K	﹤0.01%	1680
2023 Q4	$17.4M	Sell	719,936 -18,061	-2%	-$392K	﹤0.01%	1672
2023 Q3	$16.3M	Sell	737,997 -19,697	-3%	-$472K	﹤0.01%	1660
2023 Q2	$19M	Buy	+757,694	New	+$19.1M	﹤0.01%	1661

Other funds holding FMED

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.31B AUM 20.77% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return

GEA

Glen Eagle Advisors Kingston, New Jersey $793M AUM 21.06% 1-Year Est. Return

GJIA

Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return

Fidelity Investments's FMED Position: Q2 2026 in Review

Fidelity Investments reduced its Fidelity Disruptive Medicine ETF (FMED) stake by 3.5% in Q2 2026, selling an estimated $657K and leaving 707,017 shares worth $20.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1882.

Fidelity Investments first reported a position in FMED in Q2 2023 and has held it in 13 quarters since. 11 funds tracked by Wall St. Rank hold FMED as of Q2 2026.

Fidelity Investments held 707,017 shares of Fidelity Disruptive Medicine ETF worth $20.2M as of Q2 2026.
Fidelity Investments sold 25,955 Fidelity Disruptive Medicine ETF shares in Q2 2026, an estimated $657K.
Fidelity Disruptive Medicine ETF made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1882 holding.
Fidelity Investments first reported a position in Fidelity Disruptive Medicine ETF in Q2 2023 and has held it in 13 quarters since.
11 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.